Can AI remedy the growing pains of digital biomarker development?
AI implementation could be a useful tool to analyse generated data. Yet, regulatory approval hurdles are in sight.
By
Medical Devices
Latest in
Medical Devices
Beyond biopsy: how noninvasive NASH tests can move the needle
There are a variety of noninvasive NASH tests currently available and under investigation—but how can they be optimised?
By
The metaverse: the next frontier in clinical trials?
Digital simulation could help break down healthcare barriers, but experts caution the clinical trials sector to go slow.
By
Women’s health clinical trials: breaking down barriers through decentralisation
Women tend to be harder to recruit for clinical trials due to socioeconomic factors. But decentralised study designs help ease…
By
Remote clinical trial monitoring uptake rises but validation questions swirl
DCT Adoption Tracker: Clinical Trials Arena reviews the burgeoning trend on remote monitoring and look into regulatory know-how needed to…
By
Patient advisors: could they change the face of medtech trials?
The FDA has released new guidance on how to integrate patient engagement in medical device clinical studies. How might patient…
By
Impact of the pandemic on routine immunisations for vaccine-preventable diseases
Routine childhood immunisation programmes have been disrupted because of Covid-19 and their implementation should be prioritised.
By
More promise for psilocybin in depression but safety remains a concern
Psilocybin showed positive signs as a potential treatment for neurological conditions, but safety concerns need to be addressed.
By